The global sleep apnea devices market is set to expand at a steady CAGR of 9.5%, growing from USD 8.2 billion in 2023 to USD ...

Worcester Sleep Dentistry - Auburn offers specialized dental solutions for snoring and sleep apnea, helping patients breathe ...

Although RMD has re-rated from its share price low of around $21.50 in October 2023, it has only just surpassed its all-time ...

ResMed stock is down today, even though the maker of CPAPs and other respiratory treatment devices had Street-beating Q2 ...

Add car wrecks to that list, a study published Jan. 21 in the journal Otolaryngology–Head and Neck Surgery, says. People with ...

The great quarter was driven by high demand for sleep-related products and growth in digital health solutions. As a specialist in sleep and respiratory health, ResMed built its reputation through ...

Sleep apnea does not go away on its own, although some of the conditions and structural factors that cause it can be treated and reversed. For instance, a septoplasty can fix a deviated septum that is ...

Welcome to the Q2 fiscal-year 2025 ResMed earnings conference call. My name is Matt and I'll be your operator for today's call. (Operator Instructions) Please note that this conference call is being ...

Medical device company ResMed (NYSE:RMD) announced better-than-expected revenue in Q4 CY2024, with sales up 10.3% year on ...